What's new

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 93, Status: Authorised

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 93, Status: Authorised

Mar 20, 2025 - 16:35
 0
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 93, Status: Authorised
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 93, Status: Authorised
Read More

Tags:

Previous Article

PSUSA/00000329/202407

Next Article

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide,...

Related Posts

Template for late submission of ICSRs to EV

Mar 14, 2025  0

Medicinal products for human use: monthly figures - Jan...

Feb 25, 2025  0

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0